ArticleMolecular and clinical oncology2025

Dual single‑nucleotide polymorphism biomarker combination for opioid selection to treat cancer pain.

Yoshihiko Fujita et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.